Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | AZN | AMGN | GILD | BMY |
| Company | Anaptysbio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 59.51 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 63.47 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 55.51 | 195.26 | 361.39 | 143.35 | 60.26 |
| Latest | 57.28 | 197.52 | 367.60 | 145.14 | 60.74 |
| Change | -3.27 | -4.01 | -11.67 | -3.08 | -1.59 |
| % Change | -5.40% | -1.99% | -3.08% | -2.08% | -2.55% |
| Volume | 952,100 | 2,648,500 | 2,870,200 | 6,944,100 | 14,758,300 |
| 20-Day Average Volume | 496,425 | 2,435,500 | 2,825,145 | 7,849,085 | 13,907,920 |
| Previous Close | 60.55 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 54.04 | 202.09 | 376.08 | 150.12 | 60.95 |
| 20-Day Raw Stochastic | 62.96% | 41.87% | 21.79% | 14.44% | 56.07% |
| 20-Day Relative Strength | 59.39 | 51.31 | 52.79 | 53.10 | 57.76 |
| Weighted Alpha | +232.77 | +34.13 | +21.88 | +32.20 | +13.33 |
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.09% since 02/26/26 | -3.17% since 02/26/26 | -3.09% since 02/26/26 | +0.95% since 02/26/26 | -0.59% since 02/26/26 |
| Low | 52.68 on 03/03/26 | 195.26 on 03/05/26 | 361.39 on 03/05/26 | 143.35 on 03/05/26 | 60.26 on 03/05/26 |
| High | 63.47 on 03/05/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +19.58% since 02/05/26 | +5.54% since 02/05/26 | -0.05% since 02/05/26 | -2.83% since 02/05/26 | +2.05% since 02/05/26 |
| Low | 46.85 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 63.47 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +29.15% since 12/05/25 | +9.51% since 12/05/25 | +11.43% since 12/05/25 | +19.73% since 12/05/25 | +16.47% since 12/05/25 |
| Low | 42.00 on 01/06/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 63.47 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +161.55% since 09/05/25 | +20.88% since 09/05/25 | +29.60% since 09/05/25 | +26.15% since 09/05/25 | +28.85% since 09/05/25 |
| Low | 17.11 on 09/16/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 63.47 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,676,508 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 27,688 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 91,280,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -145,230,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 76,320,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 15,110,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.32 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.52 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/04/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |